Zobrazeno 1 - 7
of 7
pro vyhledávání: '"P. M. Dainer"'
Autor:
W. Rainey Johnson, Nicholas G. Roney, Hanbing Zhou, Geoffrey E. Ciarlone, Brian T. Williams, William T. Green, Richard T. Mahon, Hugh M. Dainer, Brett B. Hart, Aaron A. Hall
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Background Significant reductions in ambient pressure subject an individual to risk of decompression illness (DCI); with incidence up to 35 per 10,000 dives. In severe cases, the central nervous system is often compromised (>80%), making DCI among th
Externí odkaz:
https://doaj.org/article/149e28970638432da7cf7e364fe78c1b
Publikováno v:
Hematology Reports, Vol 8, Iss 4 (2016)
Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematologic malignancy that often results in transfusion dependency and a hypercoagulable state. This rare disease currently lacks formal guidelines for trea
Externí odkaz:
https://doaj.org/article/8563f6ceacce49a2b0ddc89519dd2d52
Publikováno v:
Hematology Reports, Vol 6, Iss 3 (2014)
Acute myeloid leukemia (AML) is a hematological malignancy of myeloid progenitor cells that disrupt normal hematopoiesis. Current chemotherapy regimens result in complete remission in many cases; however, there exists no standard efficacious therapy
Externí odkaz:
https://doaj.org/article/e1cdd085774448b1bbce4cfae3a76149
Publikováno v:
Annals of Hematology. 81:609-610
We report the successful administration of interleukin-11 (IL-11 or oprelvekin), a promoter of megakaryocyte maturation, to a 54-year-old male Jehovah's Witness with hepatic cirrhosis and hypersplenic thrombocytopenia requiring surgery for symptomati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9422cea89f8c35d99a34b08dc36027a
https://doi.org/10.1007/s00277-002-0507-y
https://doi.org/10.1007/s00277-002-0507-y
Publikováno v:
Anticancer research. 11(2)
Experiments were designed to establish whether the response of the Lewis lung tumor (LLca) to combined 5-Fluorouracil (5-FU) and radiation could be enhanced by the addition of the reduced folate leucovorin (LV) to the treatment protocol. Twenty-four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8e21a05cbc116468474b2a6f82ab5f8
https://pubmed.ncbi.nlm.nih.gov/2064349
https://pubmed.ncbi.nlm.nih.gov/2064349
Publikováno v:
The American journal of pediatric hematology/oncology. 7(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d6182ff93ee32b5c2c7e0084f172f9e
https://pubmed.ncbi.nlm.nih.gov/3842566
https://pubmed.ncbi.nlm.nih.gov/3842566
Autor:
P M, Dainer, J C, Phares
Publikováno v:
American family physician. 30(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4d3307b57e2f0176d5f2b29b80c6622
https://pubmed.ncbi.nlm.nih.gov/6540976
https://pubmed.ncbi.nlm.nih.gov/6540976